ITRM20030393A1 - Uso di oligonucleotidi (odn) antisenso per smad7 per il trattamento delle patologie mediate dal fattore di trascrizione nucleare nf-kb. - Google Patents

Uso di oligonucleotidi (odn) antisenso per smad7 per il trattamento delle patologie mediate dal fattore di trascrizione nucleare nf-kb.

Info

Publication number
ITRM20030393A1
ITRM20030393A1 IT000393A ITRM20030393A ITRM20030393A1 IT RM20030393 A1 ITRM20030393 A1 IT RM20030393A1 IT 000393 A IT000393 A IT 000393A IT RM20030393 A ITRM20030393 A IT RM20030393A IT RM20030393 A1 ITRM20030393 A1 IT RM20030393A1
Authority
IT
Italy
Prior art keywords
smad7
odn
antisense
oligonucleotides
treatment
Prior art date
Application number
IT000393A
Other languages
English (en)
Inventor
Giovanni Monteleone
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Spa filed Critical Giuliani Spa
Priority to IT000393A priority Critical patent/ITRM20030393A1/it
Publication of ITRM20030393A0 publication Critical patent/ITRM20030393A0/it
Priority to PCT/IT2004/000451 priority patent/WO2005014011A1/en
Publication of ITRM20030393A1 publication Critical patent/ITRM20030393A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/312—Phosphonates
    • C12N2310/3125—Methylphosphonates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/334—Modified C
    • C12N2310/3341—5-Methylcytosine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/34—Spatial arrangement of the modifications
    • C12N2310/345—Spatial arrangement of the modifications having at least two different backbone modifications
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/34—Spatial arrangement of the modifications
    • C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
IT000393A 2003-08-11 2003-08-11 Uso di oligonucleotidi (odn) antisenso per smad7 per il trattamento delle patologie mediate dal fattore di trascrizione nucleare nf-kb. ITRM20030393A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000393A ITRM20030393A1 (it) 2003-08-11 2003-08-11 Uso di oligonucleotidi (odn) antisenso per smad7 per il trattamento delle patologie mediate dal fattore di trascrizione nucleare nf-kb.
PCT/IT2004/000451 WO2005014011A1 (en) 2003-08-11 2004-08-06 Use of smad 7 antisense oligonucleotides (odn) for the treatment of diseases mediated by the nuclear transcription factor nf-kb

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000393A ITRM20030393A1 (it) 2003-08-11 2003-08-11 Uso di oligonucleotidi (odn) antisenso per smad7 per il trattamento delle patologie mediate dal fattore di trascrizione nucleare nf-kb.

Publications (2)

Publication Number Publication Date
ITRM20030393A0 ITRM20030393A0 (it) 2003-08-11
ITRM20030393A1 true ITRM20030393A1 (it) 2005-02-12

Family

ID=30131545

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000393A ITRM20030393A1 (it) 2003-08-11 2003-08-11 Uso di oligonucleotidi (odn) antisenso per smad7 per il trattamento delle patologie mediate dal fattore di trascrizione nucleare nf-kb.

Country Status (2)

Country Link
IT (1) ITRM20030393A1 (it)
WO (1) WO2005014011A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030149A1 (it) 2003-04-02 2004-10-03 Giuliani Spa Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
CA2743329C (en) 2008-11-13 2020-09-01 Giuliani International Limited Antisense compositions and methods of making and using same
JP6348484B2 (ja) * 2012-04-18 2018-06-27 ノグラ ファーマ リミテッド 糖尿病を処置する方法および／または移植後の膵島の生存を促進する方法
US10006029B2 (en) 2013-03-15 2018-06-26 Nogra Pharma Limited Methods of treating colorectal cancer
ES2673209T3 (es) * 2013-03-15 2018-06-20 Nogra Pharma Limited Procedimientos de tratamiento del cáncer colorrectal
WO2018122376A1 (en) * 2016-12-30 2018-07-05 Nogra Pharma Limited Compositions of smad7 antisense oligonucleotide and methods of treating or preventing psoriasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159697A (en) * 2000-01-19 2000-12-12 Isis Pharmaceuticals, Inc. Antisense modulation of Smad7 expression

Also Published As

Publication number Publication date
WO2005014011A1 (en) 2005-02-17
ITRM20030393A0 (it) 2003-08-11

Similar Documents

Publication Publication Date Title
ITRM20030149A0 (it) Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico.
HUP0301805A3 (en) Antisense oligonucleotides against vanilloid receptor 1
BR0103754B1 (pt) artigo descartÁvel.
IT1318644B1 (it) Procedimento per la denitrificazione delle acque.
ATE393614T1 (de) Enganliegende, flüssigkeitsaustritt- widerstandsfähige damenbinde
ITRM20030393A1 (it) Uso di oligonucleotidi (odn) antisenso per smad7 per il trattamento delle patologie mediate dal fattore di trascrizione nucleare nf-kb.
IT1316505B1 (it) Struttura di dispositivo di regolazione, particolarmente per attacchida sci.
AU2003242678A8 (en) Antisense oligonucleotides against pim1
ITRM20030178A0 (it) Uso della l-carnitina per il trattamento di patologie cardiovascolari.
IS8176A (is) DNA byggðar aptamerur fyrir mennskt katepsín G
IT1316387B1 (it) Dispensatore di pastura per pescatori
IT1318605B1 (it) Procedimoento per il dosaggio di tossine dsp del gruppo delledinophysitossine e delle yessottossine.
ITTO20030218A1 (it) Sonda, in particolare per cavita' tubolari.
IT249482Y1 (it) Prolunga per apparecchio infusore di farmaci.
ITMI20002152A0 (it) Metodo di preparazione del paclitaxel
ITBO20000466A0 (it) Supporto per strumenti odontoiatrici accessori in riuniti dentali .
ITMI20031072A1 (it) Ceramica biodegradabile per uso medico.
ITMI20031318A1 (it) Supporto per stoviglie monouso.
DK1324794T3 (da) Justerbar doseringspröjte
FR2825347B1 (fr) Barrette presse-tubes autoblocante
SE0001349D0 (sv) Utmatningssystem till såsmaskin
ITMC20030045A1 (it) Scaffale per il supporto delle calzature in corso di lavorazione.
ES1046961Y (es) Ducha adaptable para disminuidos fisicos.
GB0324864D0 (en) Use of antisense oligo arrays to determine the tertiary structure of nucleic acids
ITMI20051982A1 (it) Uso di small interfering rna sirna per il trattamento di patologie caratterizzate da iperproliferazione cellulare